Altimmune (ALT)
(Delayed Data from NSDQ)
$7.26 USD
+0.06 (0.83%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.25 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ALT 7.26 +0.06(0.83%)
Will ALT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ALT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ALT
Altimmune (ALT) Moves to Buy: Rationale Behind the Upgrade
Altimmune (ALT) to Report Q4 Earnings: What's in the Cards?
ALT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Altimmune (ALT) Rises 83% on Successful Phase II Obesity Study
Altimmune (ALT) Rises 7% on Completing Dosing in Obesity Study
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval
Other News for ALT
ALT January 2026 Options Begin Trading
Altimmune Statement on the Passing of Dr. Stephen Harrison
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
3 Potential Biopharma Buyout Targets
Alternus Clean Energy, Inc. Announces Closing of $2.16 Million Private Placement of Convertible Notes and Warrants